Online CME (Non-SHM) Event Listing

 

SHMConsults — Consultative and Perioperative Medicine for Hospitalists (formerly known as Johns Hopkins Consultative Medicine Essentials)

Hospitalists are the fastest growing portion of the physician work force. Some estimate there will be 50,000 hospitalists needed in the next 10 years. As the number of hospitalists grows, so too will the clinical settings in which we practice. Consultative medicine is a service provided by many hospitalists, and a future in which almost all surgical patients are co-managed by hospitalists is already a reality for some. For many of us, our training in consultative medicine during residency was limited. We hope this curriculum will help you to feel more confident about your knowledge and skills and will lead to better patient outcomes. We welcome your comments and suggestions for future topics.

View the SHMConsults page.




AHRQ's Effective Healthcare Program's Free Online CME/CE Activities

The Agency for Healthcare Research and Quality (AHRQ) sponsors CME/CE activities that are developed from systematic reviews of evidence on a wide range of topics. Please click here to view the available activities.

For free online AHRQ CME/CE programs highlighting research findings in patient-centered outcomes research, also known as comparative effectiveness research, click here.




Outcomes for VTE Prophylaxis and Treatment: Rationale for Use of New Oral Anticoagulants
August 5, 2015 thru August 5, 2016 at 12:00 p.m. - 1:00 p.m.
Sponsored by Integrity Continuing Education

Venous thromboembolism (VTE) is a common, lethal disorder that affects hospitalized and nonhospitalized patients, recurs frequently, is often overlooked, and results in long-term morbidity and life-threatening complications. The disease is the 3rd most common cardiovascular illness after acute coronary syndrome and stroke and its continuum includes deep vein thrombosis and pulmonary embolisms.

Objectives:

Describe risk factors to accurately identify patients at high risk for development of VTE and tests to diagnose/confirm VTE Compare the safety and efficacy of new oral anticoagulants and older agents for the prevention and treatment of VTE Review clinical practice guidelines to optimally treat and manage patients with provoked and unprovoked VTE Implement strategies to educate patients and improve quality of care in VTE Provide accurate and appropriate counsel as part of the treatment team Provide appropriate care and counsel for patients and their families.

CME Accreditation Statement:

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.




Preventing Thromboembolic Events in Patients with Atrial Fibrillation Using New Oral Anticoagulants
August 5, 2015 thru August 5, 2016 at 12:00 p.m. - 1:00 p.m.
Sponsored by Integrity Continuing Education

Atrial fibrillation (AF) is prevalent in an estimated 2.2 million people in the United States and is responsible for 461,000 hospitalizations annually. It has been documented that prevalence of AF increases with age and its incidence is >75,000 per year. AF has been shown to be closely associated with hypertension and coronary heart disease and can also occur in other conditions such as chronic obstructive pulmonary disease, peripartum cardiomyopathy, lupus myocarditis, and pericarditis.

Objectives:

Describe risk assessment measures to accurately stratify patients with AF for optimal treatment Compare the efficacies and limitations of currently available and emerging anticoagulation treatments, including NOACs Review recommendations from latest guidelines to tailor thromboprophylactic treatments for patients with nonvalvular AF (NVAF) Discuss measures to elicit patient preferences in treatment decisions and strategies to improve patient education and adherence Provide accurate and appropriate counsel as part of the treatment team Provide appropriate care and counsel for patients and their families.

CME Accreditation Statement:

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.




Examining the Standard of Care for Patients with Hepatic Encephalopathy: Newer Strategies for Long-term Treatment
August 5, 2015 thru August 5, 2016 at 12:00 p.m. - 1:00 p.m.
Sponsored by Integrity Continuing Education

Hepatic encephalopathy (HE) is a potentially reversible state of impaired cognitive function or altered consciousness in patients with acute or chronic liver disease or portosystemic shunting. The level of neurologic and psychiatric impairment can vary from a subtly altered mental status to a deep coma. HE has been shown to have a substantial burden on patients, their families and caregivers, as well as healthcare utilization.

Objectives:

Describe the burden and need to prevent recurrence of rehospitalizations for overt HE Evaluate the efficacy and safety of available and emerging agents for secondary prophylaxis of HE Develop a multidimensional management plan that includes long-term treatment strategies, as well as nonpharmacologic strategies, to care for patients with HE Provide accurate and appropriate counsel as part of the treatment team Provide appropriate care and counsel for patients and their families

CME Accreditation Statement:

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Creditâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.




Evaluating Hospital-based Care Strategies for the COPD Patient Care Pathway
August 5, 2015 thru August 5, 2016 at 12:00 p.m. - 1:00 p.m.
Sponsored by Integrity Continuing Education

Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory condition characterized by progressive airflow limitation resulting in high morbidity and mortality. It is highly variable with regard to the severity of its presentation, exacerbations, and comorbidities from person to person.

Objectives:

Implement guideline-recommended strategies to accurately evaluate patients presenting with acute COPD exacerbations Describe evidence-based pharmacologic treatment strategies for the management of patients with COPD Identify nonpharmacologic strategies for long-term management of COPD and the associated benefits to health outcomes Identify patient-specific factors that impact their ability to adhere to COPD treatment regimens Provide accurate and appropriate counsel as part of the treatment team Provide appropriate care and counsel for patients and their families.

CME Accreditation Statement:

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Creditâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.




 

AHRQ's Effective Healthcare Program's Free Online CME/CE Activities

The Agency for Healthcare Research and Quality (AHRQ) sponsors CME/CE activities that are developed from systematic reviews of evidence on a wide range of topics. Please click here to view the available activities.

For free online AHRQ CME/CE programs highlighting research findings in patient-centered outcomes research, also known as comparative effectiveness research, click here.